BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31832930)

  • 21. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
    Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
    PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.
    Zhang J; Alam SM; Bouton-Verville H; Chen Y; Newman A; Stewart S; Jaeger FH; Montefiori DC; Dennison SM; Haynes BF; Verkoczy L
    J Immunol; 2014 Feb; 192(4):1693-706. PubMed ID: 24465011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Melnychuk L; Ajamian L; Jean-Pierre P; Liang J; Gheorghe R; Wainberg MA; Zaharatos GJ
    Vaccine; 2017 May; 35(20):2736-2744. PubMed ID: 28392143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER.
    Apellániz B; Nieva JL
    Adv Protein Chem Struct Biol; 2015; 99():15-54. PubMed ID: 26067815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing Antibodies Targeting HIV-1 gp41.
    Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.
    Molinos-Albert LM; Bilbao E; Agulló L; Marfil S; García E; Rodríguez de la Concepción ML; Izquierdo-Useros N; Vilaplana C; Nieto-Garai JA; Contreras FX; Floor M; Cardona PJ; Martinez-Picado J; Clotet B; Villà-Freixa J; Lorizate M; Carrillo J; Blanco J
    Sci Rep; 2017 Jan; 7():40800. PubMed ID: 28084464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.
    Donius LR; Cheng Y; Choi J; Sun ZY; Hanson M; Zhang M; Gierahn TM; Marquez S; Uduman M; Kleinstein SH; Irvine D; Love JC; Reinherz EL; Kim M
    J Virol; 2016 Oct; 90(19):8875-90. PubMed ID: 27466419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.
    Mabrouk MT; Huang WC; Deng B; Li-Purcell N; Seffouh A; Ortega J; Ekin Atilla-Gokcumen G; Long CA; Miura K; Lovell JF
    Int J Pharm; 2020 Nov; 589():119843. PubMed ID: 32890653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
    Mohan T; Verma P; Rao DN
    Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
    Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y
    J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
    Pinto D; Fenwick C; Caillat C; Silacci C; Guseva S; Dehez F; Chipot C; Barbieri S; Minola A; Jarrossay D; Tomaras GD; Shen X; Riva A; Tarkowski M; Schwartz O; Bruel T; Dufloo J; Seaman MS; Montefiori DC; Lanzavecchia A; Corti D; Pantaleo G; Weissenhorn W
    Cell Host Microbe; 2019 Nov; 26(5):623-637.e8. PubMed ID: 31653484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
    Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.
    Yu Y; Tong P; Li Y; Lu Z; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):117-27. PubMed ID: 24369352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment.
    Huang WC; Deng B; Seffouh A; Ortega J; Long CA; Suresh RV; He X; Miura K; Lee SM; Wu Y; Lovell JF
    NPJ Vaccines; 2020; 5(1):23. PubMed ID: 32218995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L; Peachman K; Steers N; Schoen J; Rao M; Polonis V; Rao V
    Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.